Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $63.99 and last traded at $47.23, with a volume of 5368896 shares traded. The stock had previously closed at $55.02.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on GRAL shares. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price target on the stock. Wolfe Research started coverage on Grail in a research note on Friday, November 15th. They set a "peer perform" rating on the stock.
Get Our Latest Stock Analysis on Grail
Grail Stock Performance
The business has a 50 day moving average of $26.32 and a 200-day moving average of $19.06.
Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. As a group, analysts expect that Grail, Inc. will post -65.16 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the stock. PVG Asset Management Corp purchased a new position in shares of Grail in the 4th quarter valued at approximately $398,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Grail in the 4th quarter valued at approximately $334,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Grail in the 4th quarter valued at approximately $1,201,000. Westwood Holdings Group Inc. acquired a new stake in shares of Grail in the 4th quarter valued at approximately $1,389,000. Finally, Squarepoint Ops LLC acquired a new stake in shares of Grail in the 4th quarter valued at approximately $1,020,000.
About Grail
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
